April 12, 2018 / 6:09 PM / 3 months ago

BRIEF-Cosmo Pharmaceuticals Says ICC Arbitral Tribunal Has Ruled That Valeant Is Not In Breach Of Uceris License Agreement

April 12 (Reuters) - Cosmo Pharmaceuticals NV:

* ANNOUNCES UNFAVOURABLE AWARD OF ARBITRAL TRIBUNAL IN RESPECT OF REQUEST TO TERMINATE UCERIS LICENSE AGREEMENT WITH VALEANT

* ICC ARBITRAL TRIBUNAL HAS RULED THAT VALEANT IS NOT IN BREACH OF UCERIS LICENSE AGREEMENT, NOTWITHSTANDING COSMO’S CLAIMS

* COSMO WILL HAVE TO REIMBURSE VALEANT APPROX.$3 MLN IN LEGAL COST Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below